Neurogene Inc. (NGNE) insider trading.
In Q3 2026, insiders at Neurogene Inc. reported 5 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $340K.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -9,600
- Insiders
- 1
- Last filed
- 2026-07-07
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Cvijic Christine Mikail | Director, Officer · President and CFO | 5 | 0 | 5 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | Cvijic Christine Mikail | S (D) | 4,200 | $36.13 | 84,040 | Form 4 |
| 2026-07-06 | Cvijic Christine Mikail | S (D) | 600 | $36.02 | 88,240 | Form 4 |
| 2026-07-02 | Cvijic Christine Mikail | S (D) | 2,531 | $34.58 | 90,370 | Form 4 |
| 2026-07-02 | Cvijic Christine Mikail | S (D) | 1,530 | $35.23 | 88,840 | Form 4 |
| 2026-07-01 | Cvijic Christine Mikail | S (D) | 739 | $34.06 | 92,901 | Form 4 |
Transaction codes in this quarter
Get NGNE insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1404644&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NGNE company page · Neurogene Inc. on SEC.gov
Questions
Are insiders buying or selling Neurogene Inc. (NGNE)?
In Q3 2026, insiders at Neurogene Inc. reported 5 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $340K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Neurogene Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/ngne.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.